-
News and Products from Trialbee, Flatiron, Sanofi, Phesi, Personalis, More
Clinical Research News | Trialbee enhances recruitment strategy; Flatiron and Sanofi set out to redesign the clinical trial experience for sponsors, sites, and patients; and Phesi has published the first edition of its Digital Patient Profile (DPP) catalog. Plus: partnerships for Culmination Bio, Cofactor Genomics, Personalis, Ono Pharmaceuticals, National Cancer Center, and more.
May 24, 2023
-
As CVS Slowly Exits Clinical Trial Business, Walgreens Continues Ramp-Up
Clinical Research News | Last week, CVS Health announced its intension to phase out of the clinical trial business with a full exit expected by the end of 2024. In a conversation with Clinical Research News, Walgreens Chief Clinical Trials Officer Ramita Tandon applauds her colleagues at CVS for being the first mover. She is also reassuring Walgreens stakeholders that “we are not going away.”
May 23, 2023
-
New Antimicrobial Susceptibility Test Suggests Generic Z-Pak Can Cure Superbugs
Clinical Research News | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs.
May 18, 2023
-
Blinded, Randomized Clinical Trial Suggests AI ‘Near-Ready For Prime Time’
Clinical Research News | In a first-of-its-kind, blinded and randomized clinical trial of artificial intelligence (AI) in cardiology, investigators at Cedars-Sinai Medical Center have shown that an “AI assistant” for assessing heart health works even better than sonographers at reading echocardiograms. The software was integrated with the institution’s picture archiving and communication system that securely stores and digitally transmits electronic images.
May 16, 2023
